FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN ADULTS.

Learn how AbbVie could help you save on QULIPTA®. Call 1-855-QULIPTA or click to learn more ›

Skip to Main content
  • Important Safety
    Information
  • Patient
    Information
  • Healthcare Professional Site
  • Cost & Savings
  • SAVINGS SIGN UP
  • TALK TO A DOCTOR NOW
Qulipta® (atogepant) tablets logo
  • Qulipta® (atogepant) tablets logo
  • Cost & Savings
  • Healthcare Professional Site
  • Home
  • About QULIPTA®
    • Why QULIPTA
    • Patient Stories
  • Savings & Resources
    • QULIPTA Complete Savings Program
    • QULIPTA discussion guide
    • Frequently asked questions
    • Find a doctor
    • Additional Resources
  • Migraine Center
  • talk to a doctor now

Follow us @

  • Facebook
  • Instagram
  • Twitter
Learn about migraine

IMPORTANT SAFETY INFORMATION

Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA.

Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:

  • Have high blood pressure
  • Have circulation problems in your fingers and toes
  • Have kidney problems or are on dialysis
  • Have liver problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines.

QULIPTA can cause serious side effects, including:

  • Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash.
  • High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
  • Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.

The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA.

QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets.

What is QULIPTA® (atogepant)?

QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.

 

US-QLP-250105

 

Please see full Patient Information.

  • Important Safety Information
  • Patient Information
  • Healthcare Professional Site
  • Sitemap
  • Accessibility Statement
  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Cookies Settings
  • Your Privacy Choices

AbbVie logo

© 2024 AbbVie. All rights reserved. 

All trademarks are the property of their respective owners. 

US-QLP-220239

Transcript

Follow us @

  • Facebook
  • Instagram
  • Twitter

FOR US CONSUMERS ONLY

SPEAK WITH A DOCTOR ONLINE TO LEARN IF QULIPTA MAY BE RIGHT FOR YOU

Talk to a doctor from the comfort of your home with convenient telemedicine appointments. Here's how:

Answer a few simple questions about your migraine attacks and current treatment plan.

Connect directly with a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript®.

If a prescription is written, you can pick it up from your local pharmacy or have it sent straight to you with at-home delivery.

By clicking “TALK WITH A DOCTOR NOW” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.

If you agree to the above, click “TALK WITH A DOCTOR NOW” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on QULIPTA.com.

TALK WITH A DOCTOR NOW
BACK TO SITE
LEAVING ABBVIE WEB SITE

You are leaving the QUILIPTA site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's endorsement of QUILIPTA.com or AbbVie.

Do you wish to leave this site?

NO
YES

US-QLP-250125

Important Safety Information

Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA.

Important Safety Information

Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA.

Important Safety Information

Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA.

Important Safety Information

Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA.

IMPORTANT SAFETY INFORMATION

Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA.

Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you:

  • Have high blood pressure
  • Have circulation problems in your fingers and toes
  • Have kidney problems or are on dialysis
  • Have liver problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines.

QULIPTA can cause serious side effects, including:

  • Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash.
  • High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
  • Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.

The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA.

QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets.

What is QULIPTA® (atogepant)?

QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.

 

US-QLP-250105